Related Experiment Videos
[B-chronic lymphocytic leukemia/prolymphocytic leukemia (CLL/PL)--a case report]
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology
|November 1, 1990
Summary
This case study presents a patient diagnosed with B-cell chronic lymphocytic leukemia/prolymphocytic leukemia (B-CLL/PL), an intermediate form of leukemia. The patient achieved partial remission with VEPA chemotherapy, highlighting a potential treatment response.
Area of Science:
- Hematology
- Oncology
- Immunology
Background:
- B-cell chronic lymphocytic leukemia/prolymphocytic leukemia (B-CLL/PL) is a distinct clinical entity.
- It presents intermediate features between chronic lymphocytic leukemia (CLL) and prolymphocytic leukemia (PLL).
- Most B-CLL/PL cases exhibit resistance to standard chemotherapy.